Skip to main content

Site notifications

Australian Public Assessment Reports (AusPAR)

Search our AusPAR dataset for information on the evaluation of prescription medicines.

Use the filters below to narrow your search.

Filter results

You can narrow down the results using the filters.

Sponsor

An AusPAR provides information about the evaluation of a prescription medicine and the considerations that led the TGA to approve or not approve an application.

For more information see Australian Public Assessment Reports for prescription medicines (AusPARs).

Search

1125 result(s) found, displaying 676 to 700
  • Australian public assessment report for Lenalidomide
  • Australian Public Assessment Report for Dabigatran etexilate
  • Australian public assessment report for Valganciclovir
  • AusPAR: Ivermectin
  • Australian Public Assessment Report for Nepafenac
  • Australian public assessment report for Arsenic trioxide
  • Australian public assessment report for Adalimumab (rch)
  • Australian Public Assessment Report for Asunaprevir
  • Australian Public Assessment Report for Rifaximin
  • Australian Public Assessment Report for Anakinra
  • Australian public assessment report for Apixaban
  • Australian public assessment report for Regorafenib
  • Australian public assessment report for Certolizumab pegol (rbe)
  • Australian public assessment report for Apremilast
  • Australian Public Assessment Report for Ledipasvir/Sofosbuvir
  • Australian Public Assessment Report for Sevelamer carbonate
  • Australian Public Assessment Report for Carglumic acid
  • Australian public assessment report for Etanercept
  • AusPAR: Secukinumab
  • Australian Public Assessment Report for Rituximab